Caricamento...
Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
In oncology, an increasing number of targeted anticancer agents and immunotherapies are of biological origin. These biological drugs may trigger immune responses that lead to the formation of antidrug antibodies (ADAs). ADAs are directed against immunogenic parts of the drug and may affect efficacy...
Salvato in:
| Pubblicato in: | Oncologist |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AlphaMed Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061540/ https://ncbi.nlm.nih.gov/pubmed/27440064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0061 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|